Enhancing IVF Success: The Potential of Primitive Endoderm Stem Cells

Updated on: June 28,2024 0

Enhancing IVF Success: The Potential of Primitive Endoderm Stem Cells

Updated on:June 28,2024 0

Research provides further evidence that epigenetic changes can cause type 2 diabetes

byLund UniversityStudy design. EPIC array DNA methylation in islets of 25 T2D cases and 75 controls. RNA-seq data were available for 25 T2D cases and 72 controls. Islet DNA methylation was assoc

Updated on: March 13,2024 5

Research provides further evidence that epigenetic changes can cause type 2 diabetes

byLund UniversityStudy design. EPIC array DNA methylation in islets of 25 T2D cases and 75 controls. RNA-seq data were available for 25 T2D cases and 72 controls. Islet DNA methylation was assoc

Updated on:March 13,2024 5

Engineered platelets can induce anti-inflammatory, immunosuppressive response, finds scientist

by Marlene Leung,St. Michael's HospitalCredit: Pixabay/CC0 Public DomainNew research led by a St. Michael's Hospital scientist reveals how platelets can inhibit inflammation and immune r

Updated on: January 27,2024 11

Engineered platelets can induce anti-inflammatory, immunosuppressive response, finds scientist

by Marlene Leung,St. Michael's HospitalCredit: Pixabay/CC0 Public DomainNew research led by a St. Michael's Hospital scientist reveals how platelets can inhibit inflammation and immune r

Updated on:January 27,2024 11

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos

Updated on: March 28,2024 0

Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos

Updated on:March 28,2024 0

Genetic diseases: How scientists are working to make DNA repair (almost) a piece of cake

FEBRUARY 6, 2024by Camille Bouchard,The ConversationCredit: Unsplash/CC0 Public DomainI have always been fascinated by genetics, a branch of biology that helps explain everything from the striki

Updated on: March 30,2024 4

Genetic diseases: How scientists are working to make DNA repair (almost) a piece of cake

FEBRUARY 6, 2024by Camille Bouchard,The ConversationCredit: Unsplash/CC0 Public DomainI have always been fascinated by genetics, a branch of biology that helps explain everything from the striki

Updated on:March 30,2024 4

Transmission risk of multidrug-resistant bacteria appears highest in hospital sinks

by Association for Professionals in Infection ControlCredit: CC0 Public DomainA newstudypublished today in theAmerican Journal of Infection Control (AJIC)reports the infection

Updated on: April 28,2024 0

Transmission risk of multidrug-resistant bacteria appears highest in hospital sinks

by Association for Professionals in Infection ControlCredit: CC0 Public DomainA newstudypublished today in theAmerican Journal of Infection Control (AJIC)reports the infection

Updated on:April 28,2024 0

Your cells are dying. All the time.

Some go gently into the night. Others die less prettily in freak accidents or deadly invasions, or after a showy display.

Updated on: October 08,2024 0

Your cells are dying. All the time.

Some go gently into the night. Others die less prettily in freak accidents or deadly invasions, or after a showy display.

Updated on:October 08,2024 0

Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis

by Tina BrownPatients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research

Updated on: March 28,2024 0

Trials shows bimekizumab response durable at four years for moderate-to-severe psoriasis

by Tina BrownPatients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research

Updated on:March 28,2024 0

How to make mRNA therapeutics safe from the start

FEBRUARY 28, 2024by Cynthia McCormick Hibbert,Northeastern UniversityScientists eager to harness mRNA technology to fight cancer and more need to find ways to test early for safety, Northeastern

Updated on: March 25,2024 6

How to make mRNA therapeutics safe from the start

FEBRUARY 28, 2024by Cynthia McCormick Hibbert,Northeastern UniversityScientists eager to harness mRNA technology to fight cancer and more need to find ways to test early for safety, Northeastern

Updated on:March 25,2024 6

Disruption of mitochondrial unfolded protein response yields shortening of telomeres in mouse oocytes, somatic cells

FEBRUARY 21, 2024by Impact Journals LLCRepresentative confocal images of TRF1 expression and TRF/H2AX co-localization in cumulus oophorus isolated from 6-month-old wild-type and Clpp−/−mice. Cre

Updated on: March 30,2024 4

Disruption of mitochondrial unfolded protein response yields shortening of telomeres in mouse oocytes, somatic cells

FEBRUARY 21, 2024by Impact Journals LLCRepresentative confocal images of TRF1 expression and TRF/H2AX co-localization in cumulus oophorus isolated from 6-month-old wild-type and Clpp−/−mice. Cre

Updated on:March 30,2024 4

Aspirin cuts liver fat in clinical trial

by Tracy Hampton,Harvard UniversityCredit: Pixabay/CC0 Public DomainThe most common chronic liver disease—metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an

Updated on: March 28,2024 0

Aspirin cuts liver fat in clinical trial

by Tracy Hampton,Harvard UniversityCredit: Pixabay/CC0 Public DomainThe most common chronic liver disease—metabolic dysfunction–associated steatotic liver disease (MASLD)—is characterized by an

Updated on:March 28,2024 0

Human cells building 'molecular highways' captured for first time

FEBRUARY 1, 2024byCenter for Genomic Regulationγ-TuRC starting the nucleation process (left) vs. γ-TuRC closing (right). Once closed, thhe foundation is set and tubulins can be added to make the

Updated on: March 25,2024 8

Human cells building 'molecular highways' captured for first time

FEBRUARY 1, 2024byCenter for Genomic Regulationγ-TuRC starting the nucleation process (left) vs. γ-TuRC closing (right). Once closed, thhe foundation is set and tubulins can be added to make the

Updated on:March 25,2024 8